In HCC, overexpression of AURKA and AURKB is associated with tumor aggressiveness, an unfavorable prognosis, and poorer outcomes [15–17], and their co-expression is an independent predictor of PFS and OS [18]. Here, AURKA is linked to hepatocellular carcinoma.